Perspective Therapeutics, Inc. (CATX) Reports In-Line Q3 EPS

Perspective Therapeutics, Inc. (NYSE: CATX) reported Q3 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $2.19 million versus the consensus estimate of $2.2 million.

For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.

You May Also Be Interested In

• Perspective Therapeutics Inc (CATX) PT Lowered to $14 at Piper Sandler
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Movano (MOVE) Misses Q2 EPS by 195c